BETHESDA, Md.--Men with high intakes of the omega-3 fatty acids
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may have a
reduced risk of prostate cancer, according to researchers from the
National Institutes of Health's National Cancer Institute (Am J Clin
Nutr, 80, 1:204-16, 2004). Increased dietary intake of alpha linolenic
acid (ALA), however, may increase the risk of advanced prostate
cancer.

Researchers evaluated the association between dietary intake of ALA,
EPA, DHA, linoleic acid (LA) and arachidonic acid (AA) and prostate
cancer risk in a cohort of 47,866 men between 40 and 75 years of age
who were free from prostate cancer at the start of the study. After 14
years of follow-up, 2,965 subjects developed prostate cancer--448 of
which developed advanced prostate cancer.

The researchers found men with the highest intake of EPA and DHA
combined had an 11-percent reduced risk of developing prostate cancer
and a 26-percent reduced risk of developing advanced prostate cancer.
Researchers also found while dietary intake of ALA was unrelated to
the total risk of prostate cancer, its consumption significantly
increased the risk of developing advanced prostate cancer.
Specifically, non-animal ALA doubled the risk and ALA from meat and
dairy sources increased the risk by approximately 50 percent.

For more information visit: http://www.prostacet.com/?aid=627156